CERS
Cerus Corp
NASDAQ · Health Care
$2.20
+0.06 (+2.80%)
Income Statement
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Revenue | 209.53M | 193.88M | 138.88M | 130.22M | 111.42M |
| Net Income | -21,763,513 | -18,124,513 | 21.45M | 25.78M | 16.47M |
| EPS | — | — | — | — | — |
| Profit Margin | -10.4% | -9.9% | 15.4% | 19.8% | 14.8% |
| Rev Growth | +8.1% | +8.1% | +17.2% | +7.1% | +0.6% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| Total Debt | 126.74M | 126.74M | 162.04M | 205.04M | 167.58M |
| Total Equity | 84.55M | 84.55M | 186.01M | 201.48M | 187.99M |
| D/E Ratio | 1.50 | 1.50 | 0.87 | 1.02 | 0.89 |
Cash Flow
| FY 2026 | FY 2025 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|---|
| EBITDA | -10,814,526 | -9,506,615 | 37.38M | 34.32M | 27.68M |
| Free Cash Flow | — | — | 34.35M | 26.52M | 27.45M |